TCF19 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the transcription factor TCF19. TCF19, or Transcription Factor 19, plays a significant role in the regulation of gene expression, particularly during the cell cycle and processes involved in cellular proliferation. As a member of the transcription factor family, TCF19 binds to specific DNA sequences in the promoter regions of its target genes, influencing their transcriptional activity. TCF19 is known to regulate genes that are crucial for cellular growth, division, and the maintenance of normal cell functions. By inhibiting TCF19, these compounds prevent its binding to DNA, thereby altering the expression of genes that it controls, which may lead to changes in cellular dynamics, especially those related to proliferation and cell cycle progression.
Research into TCF19 inhibitors provides valuable insights into the role of TCF19 in maintaining cellular homeostasis and regulating critical phases of the cell cycle. By blocking the activity of TCF19, scientists can study how changes in gene expression affect cellular processes such as DNA replication, mitosis, and cellular growth. These inhibitors allow researchers to explore the function of TCF19 in various contexts, such as how it contributes to the coordination of transcriptional programs during different stages of the cell cycle. Additionally, TCF19 inhibitors are useful tools for investigating the broader mechanisms of transcription factor regulation and how specific transcription factors interact with other proteins to orchestrate complex gene regulatory networks. Overall, the study of TCF19 inhibitors deepens our understanding of transcriptional control in cellular proliferation and the molecular mechanisms that govern cell cycle regulation and gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may downregulate TCF19 expression by inducing hypomethylation of its gene promoter, which can lead to transcriptional repression of the gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A could decrease TCF19 expression by altering chromatin compaction, thus hindering the initiation of transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid might reduce TCF19 expression by promoting a more closed chromatin state, thereby obstructing the binding of transcription machinery to the TCF19 gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could suppress TCF19 expression by binding to nuclear receptors that repress the transcription of specific target genes, including TCF19. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to specific DNA sequences, Mithramycin A possibly could inhibit the transcriptional initiation of TCF19 by blocking essential transcription factor sites. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine might lead to a reduction in TCF19 expression by DNA demethylation, resulting in transcriptional silencing of the gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could indirectly lead to a decrease in TCF19 expression by inhibiting the mTOR pathway, which is involved in the regulation of protein synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D could inhibit TCF19 expression by intercalating into DNA and preventing the elongation phase of RNA transcription by RNA polymerase. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Through the activation of protein kinase C, PMA could lead to a decrease in TCF19 expression by altering the activity of transcription factors that control the gene's expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin could downregulate TCF19 expression by intercalating DNA and inhibiting the topoisomerase II enzyme, disrupting the transcription process of the gene. | ||||||